Galmed Pharmaceuticals Announces Proposed Offering of Ordinary Shares
- Tuesday, February 16, 2021, 7:11
- PR Newswire
- Add a comment
TEL AVIV, Israel, Feb. 16, 2021 /PRNewswire/ — Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) (“Galmed” or the “Company”), a clinical-stage biopharmaceutical company for liver, metabolic and inflammatory diseases, today announced that it is commencing an underwritten public offering of its…
About the Author
admin has written 20655 stories on this site.